Literature DB >> 28562737

Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review.

Everton Cazzo1, José Carlos Pareja2, Elinton Adami Chaim3.   

Abstract

CONTEXT AND
OBJECTIVE: : Nonalcoholic fatty liver disease (NAFLD) has been increasingly diagnosed worldwide and is now recognized as a source of public health concern. It comprises a wide spectrum of histological features that range from simple steatosis to severe forms of fibrosis, steatohepatitis and even cirrhosis. The impact of bariatric surgery on the course of NAFLD in individuals with obesity has been extensively studied. DESIGN AND
SETTING: : Narrative review; public university hospital.
METHODS: : A comprehensive review was conducted based on an online search on the electronic databases MEDLINE and LILACS using the MeSH terms "fatty liver" and "bariatric surgery".
RESULTS: : The exact mechanisms that lead to improvement in NAFLD following bariatric surgery are not completely understood. Since Roux-en-Y gastric bypass (RYGB) is the bariatric surgical procedure most performed worldwide, it is also the one from which the effects on NAFLD have been most studied, although there is also consistent evidence regarding the effects from gastric banding, sleeve gastrectomy and biliopancreatic diversions.
CONCLUSION: : According to the currently available evidence, bariatric surgery leads to significant improvement in NAFLD. Further research, especially by means of randomized controlled trials enrolling larger cohorts of individuals, is needed to determine the optimal procedure for this group of subjects.

Entities:  

Mesh:

Year:  2017        PMID: 28562737     DOI: 10.1590/1516-3180.2016.0306311216

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  8 in total

1.  Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study.

Authors:  Tiago Bezerra de Freitas Diniz; Rafael Nascimento de Jesus; Laísa Simakawa Jimenez; José Carlos Pareja; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

2.  Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center.

Authors:  Shivanshu Misra; B Deepa Nandhini; S Christinajoice; S Saravana Kumar; S Prabhakaran; C Palanivelu; P Praveen Raj
Journal:  Obes Surg       Date:  2020-07-29       Impact factor: 4.129

Review 3.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

4.  Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.

Authors:  Laísa Simakawa Jimenez; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; Murillo Pimentel Utrini; Martinho Antonio Gestic; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

5.  The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods.

Authors:  Maurizio Soresi; Daniela Cabibi; Rosaria V Giglio; Stefania Martorana; Giuseppina Guercio; Rossana Porcasi; Antonino Terranova; Luigi A Lazzaro; Maria R Emma; Giuseppa Augello; Melchiorre Cervello; Gianni Pantuso; Giuseppe Montalto; Lydia Giannitrapani
Journal:  Biomed Res Int       Date:  2020-04-26       Impact factor: 3.411

Review 6.  Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation.

Authors:  Revathy Carnagarin; Kearney Tan; Leon Adams; Vance B Matthews; Marcio G Kiuchi; Leslie Marisol Lugo Gavidia; Gavin W Lambert; Elisabeth A Lambert; Lakshini Y Herat; Markus P Schlaich
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

7.  An Unusual Long-Term Complication of Bariatric Surgery.

Authors:  Cassandra M Voong; Kenneth J Vega; Ahmad Alkaddour
Journal:  Cureus       Date:  2022-04-07

8.  Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic.

Authors:  Ayşegül Avcu; Eda Kaya; Yusuf Yilmaz
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.